234 related articles for article (PubMed ID: 26700118)
1. Can Stereotactic Body Radiotherapy Effectively Treat Hepatocellular Carcinoma?
Barry A; Knox JJ; Wei AC; Dawson LA
J Clin Oncol; 2016 Feb; 34(5):404-8. PubMed ID: 26700118
[TBL] [Abstract][Full Text] [Related]
2. Radioembolization in Advanced Hepatocellular Carcinoma.
Riaz A; Lewandowski R; Salem R
J Clin Oncol; 2018 Jul; 36(19):1898-1901. PubMed ID: 29718791
[TBL] [Abstract][Full Text] [Related]
3. Gastric radiation enteritis after intra-arterial yttrium-90 microsphere therapy for early stage hepatocellular carcinoma.
Aloia TA; Barakat O; Connelly J; Haykal N; Michel D; Gaber AO; Ghobrial RM
Exp Clin Transplant; 2009 Sep; 7(3):141-4. PubMed ID: 19715522
[TBL] [Abstract][Full Text] [Related]
4. Threshold doses for focal liver reaction after stereotactic ablative body radiation therapy for small hepatocellular carcinoma depend on liver function: evaluation on magnetic resonance imaging with Gd-EOB-DTPA.
Sanuki N; Takeda A; Oku Y; Eriguchi T; Nishimura S; Aoki Y; Mizuno T; Iwabuchi S; Kunieda E
Int J Radiat Oncol Biol Phys; 2014 Feb; 88(2):306-11. PubMed ID: 24411601
[TBL] [Abstract][Full Text] [Related]
5. Outcomes following definitive stereotactic body radiotherapy for patients with Child-Pugh B or C hepatocellular carcinoma.
Culleton S; Jiang H; Haddad CR; Kim J; Brierley J; Brade A; Ringash J; Dawson LA
Radiother Oncol; 2014 Jun; 111(3):412-7. PubMed ID: 24906626
[TBL] [Abstract][Full Text] [Related]
6. Alpha-fetoprotein has no prognostic role in small hepatocellular carcinoma identified during surveillance in compensated cirrhosis.
Giannini EG; Marenco S; Borgonovo G; Savarino V; Farinati F; Del Poggio P; Rapaccini GL; Anna Di Nolfo M; Benvegnù L; Zoli M; Borzio F; Caturelli E; Chiaramonte M; Trevisani F;
Hepatology; 2012 Oct; 56(4):1371-9. PubMed ID: 22535689
[TBL] [Abstract][Full Text] [Related]
7. Postoperative Management of Resected Brain Metastases: When Can Radiotherapy Be Deferred?
Mehta MP; Kotecha R
J Clin Oncol; 2018 Oct; ():JCO2018793232. PubMed ID: 30296192
[TBL] [Abstract][Full Text] [Related]
8. Effect of Daily and Every Other Day Stereotactic Body Radiation Therapy Schedules on Treatment-Related Fatigue in Patients With Hepatocellular Carcinoma.
Hasan S; Renz P; Packard M; Horrigan S; Gresswell S; Kirichenko AV
Pract Radiat Oncol; 2019 Jan; 9(1):e38-e45. PubMed ID: 30612721
[TBL] [Abstract][Full Text] [Related]
9. Management of refractory metastatic anal squamous cell carcinoma following disease progression on traditional chemoradiation therapy.
Silva NN; Eng C
J Adv Pract Oncol; 2012 May; 3(3):161-9. PubMed ID: 25031942
[TBL] [Abstract][Full Text] [Related]
10. Influence of clinically significant portal hypertension on survival after hepatic resection for hepatocellular carcinoma in cirrhotic patients.
Giannini EG; Savarino V; Farinati F; Ciccarese F; Rapaccini G; Marco MD; Benvegnù L; Zoli M; Borzio F; Caturelli E; Chiaramonte M; Trevisani F;
Liver Int; 2013 Nov; 33(10):1594-600. PubMed ID: 23654354
[TBL] [Abstract][Full Text] [Related]
11. Emergency liver resection for ruptured hepatocellular carcinoma complicating cirrhosis.
Chiappa A; Zbar A; Audisio RA; Paties C; Bertani E; Staudacher C
Hepatogastroenterology; 1999; 46(26):1145-50. PubMed ID: 10370682
[TBL] [Abstract][Full Text] [Related]
12. How can we treat a patient with liver cirrhosis (hepatitis C virus), hepatocellular carcinoma, and synchronous colon cancer?
Antoniou E; Mantas D; Paraskeva P; Dimitroulis D; Smyrnis A; Nikitakis N; Labadariou A; Tsavaris N; Vernicos P; Kostakis A
Transplant Proc; 2012 Nov; 44(9):2745-7. PubMed ID: 23146511
[TBL] [Abstract][Full Text] [Related]
13. [Efficacy of radiofrequency ablation to treat advanced hepatocellular carcinoma].
Wu J; Chen MH; Yang W; Wu W; Yan K
Zhonghua Gan Zang Bing Za Zhi; 2012 Apr; 20(4):256-60. PubMed ID: 22964144
[TBL] [Abstract][Full Text] [Related]
14. Clinical implications of basic research in hepatocellular carcinoma.
Dhanasekaran R; Venkatesh SK; Torbenson MS; Roberts LR
J Hepatol; 2016 Mar; 64(3):736-45. PubMed ID: 26450813
[TBL] [Abstract][Full Text] [Related]
15. Immune Checkpoint Blockade in PD-L1-Positive Platinum-Refractory Cervical Carcinoma.
Tewari KS
J Clin Oncol; 2019 Jun; 37(17):1449-1454. PubMed ID: 31026210
[No Abstract] [Full Text] [Related]
16. Revisiting the role of nonanatomic resection of small (< or = 4 cm) and single hepatocellular carcinoma in patients with well-preserved liver function.
Kang CM; Choi GH; Kim DH; Choi SB; Kim KS; Choi JS; Lee WJ
J Surg Res; 2010 May; 160(1):81-9. PubMed ID: 19577249
[TBL] [Abstract][Full Text] [Related]
17. Hepatocellular carcinoma: Can it be considered a controversial indication for liver transplantation in centers with high rates of hepatitis C?
Moya A; Berenguer M; Aguilera V; Juan FS; Nicolás D; Pastor M; López-Andujar R; Rayón M; Orbis F; Mora J; De Juan M; Carrasco D; Vila JJ; Prieto M; Berenguer J; Mir J
Liver Transpl; 2002 Nov; 8(11):1020-7. PubMed ID: 12424715
[TBL] [Abstract][Full Text] [Related]
18. [Surgical therapy of hepatic fibrolamellar carcinoma].
Meriggi F; Forni E
Ann Ital Chir; 2007; 78(1):53-8. PubMed ID: 17518332
[TBL] [Abstract][Full Text] [Related]
19. Debulking surgery followed by intraarterial 5-fluorouracil chemotherapy plus subcutaneous interferon alfa for massive hepatocellular carcinoma with multiple intrahepatic metastases: a pilot study.
Tanaka K; Yabushita Y; Nakagawa K; Kumamoto T; Matsuo K; Taguri M; Endo I
Eur J Surg Oncol; 2013 Dec; 39(12):1364-70. PubMed ID: 24183169
[TBL] [Abstract][Full Text] [Related]
20. Optimizing Treatment Risk and Benefit for Elderly Patients With Advanced Non-Small-Cell Lung Cancer: The Right Treatment for the Right Patient.
Presley CJ; Gross CP; Lilenbaum RC
J Clin Oncol; 2016 May; 34(13):1438-42. PubMed ID: 27001591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]